全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1980063-54-4 | 4-(Difluoromethyl)aniline hydrochloride | C7H8ClF2N |
| 1980785-05-4 | Methanesulfonato(Di-tert-butyl(2',4',6'-triisopropyl-3,6-dimethoxybiphenyl-2-yl)phosphine)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) | C45H65NO5PPdS- |
| 1985605-59-1 | Baloxavir;(12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-ff][1,2,4]triazine-6,8-dione | C24H19F2N3O4S |
| 1985606-14-1 | Baloxavir marboxil;({(12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl}oxy)methyl methyl carbonate; Baloxavir marboxil; S 033188; Xofluza | C27H23F2N3O7S |
| 1985607-70-2 | (12aR)-3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione;(3R)-11-phenylmethoxy-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-9,12-dione | C17H17N3O4 |
| 1985607-83-7 | 7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol | C14H10F2OS |
| 1987887-92-2 | Nintedanib N-Methyl aniline analog;methyl 2-hydroxy-3-[N-[4-(methylamino)phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate | C24H21N3O3 |
| 1987905-93-0 | Ibrutinib impurity 6;1,3-bis[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one | C47H46N12O3 |
| 1991986-30-1 | 2-[[(4-Methylphenyl)sulfonyl]amino]-N-(4-phenyl-2-thiazolyl)-4-(trifluoromethyl)benzamide | C24H18F3N3O3S2 |
| 1997361-85-9 | Semaglutide Acetate;acetic acid;18-[[(1S)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-18-oxooctadecanoic acid | C189H295N45O61 |
| 2002381-31-7 | 6,7-Dimethoxy-N-(2-methyl-4-phenoxyphenyl)-4-quinazolinamine hydrochloride (1:1) | C23H21N3O3.HCl |
| 2004659-83-8 | Sorafenib Related Compound 11;N-methyl-4-[4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]pyridine-2-carboxamide | C20H19N5O3 |
| 2004659-84-9 | Sorafenib EP Impurity B;4-[4-(Formylamino)phenoxy]-N-methyl-2-pyridinecarboxamide | C14H13N3O3 |
| 2007924-97-0 | Methyl (3R,5S)-rel-5-(trifluoromethyl)piperidine-3-carboxylate HCl | C8H13ClF3NO2 |
| 2009020-38-4 | [2'-(amino-κN)[1,1'-biphenyl]-2-yl-κC][bis(1,1-dimethylethyl)[3-methoxy-6-methyl-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine-κP](methanesulfonato-κO)-Palladium;RockPhos Pd G3 | C44H62NO4PPdS |
| 2009273-71-4 | 6'-Amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-[3,3'-bipyridine]-6-carboxamide | C20H20N4O2 |
| 2012607-27-9 | N-(1,1-Dimethylethyl)-1-[1-[5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]-4-piperidinyl]-1H-imidazole-5-carboxamide;WNK 463 | C21H24F3N7O2 |
| 2023006-41-7 | t-Butyl (4S)-4-(methoxymethyl)-2,2-dioxo-oxathiazolidine-3-carboxylate | C9H17NO6S |
| 2023788-19-2 | Tirzepatide;LY 3298176; LY3298176; 20-[[4-[2-[2-[2-[2-[2-[2-[[5-[[5-amino-2-[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]propanoylamino]-5-oxopentanoyl]amino]-6-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[1-[[2-[[2-[2-[[1-[[1-[[2-[[1-[2-[2-[2-[(1-amino-3-hydroxy-1-oxopropan-2-yl)carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid | C225H348N48O68 |
| 2029049-79-2 | N-[3-oxo-3-[[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]propyl]-4-(trifluoromethoxy)-benzamide | C21H21F3N2O3 |
| 2029205-64-7 | 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C24H22ClN5O3 |
| 2030182-41-1 | 3-(3-Chloro-4-methoxyphenyl)-1,1-bis[(2H3)methyl]urea | C10H7D6ClN2O2 |
| 2030242-21-6 | Enzalutamide Impurity 7;Enzalutamide metabolite M7;4-[3-[3-fluoro-4-(methylcarbamoyl)phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzamide | C21H18F4N4O3S |
| 2031255-23-7 | Ibrutinib dimer;1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-[[3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]pyrazolo[3,4-d]pyrimidin-4-yl]amino]propan-1-one | C50H48N12O4 |
| 2036272-55-4 | 1,1'-[[(4-Hydroxybutyl)imino]di-6,1-hexanediyl] bis(2-hexyldecanoate);ALC-0315 | C48H95NO5 |
| 2040291-27-6 | (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol | C17H18N4O4 |
| 2040295-03-0 | Pexidartinib Hydrochloride;5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine;hydrochloride | C20H16Cl2F3N5 |
| 2044702-38-5 | Fmoc-N-Me-Dab(Boc)-OH;2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid | C25H30N2O6 |
| 2044702-39-6 | Osimertinib Impurity G;N-(2-(Dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide | C25H26N6O2 |
| 2044709-88-6 | N2-[(1,1-Dimethylethoxy)carbonyl]-N6-[(9H-fluoren-9-ylmethoxy)carbonyl]-N2-methyl-D-lysine | C27H34N2O6 |
| 2044710-35-0 | N6-[(1,1-Dimethylethoxy)carbonyl]-N2-methyl-D-lysine methyl ester hydrochloride (1:1) | C13H26N2O4.HCl |
| 2044710-37-2 | N-Methyl-D-norleucine hydrochloride (1:1) | C7H15NO2.HCl |
| 2044710-64-5 | N5-[(1,1-Dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N2-methyl-D-ornithine | C26H32N2O6 |
| 2045402-27-3 | alpha Hydroxy montelukast;2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]-2-hydroxyacetic acid | C35H36ClNO4S |
| 2049025-67-2 | Carfilzomib Impurity 12;(S)-4-Methyl-N-((S)-1-(((R)-4-Methyl-1-((S)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide | C40H57N5O7 |
| 2049980-18-7 | Azelaprag;(2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide | C25H29N7O4S |
| 2050017-52-0 | (2S,3R)-3-(5-Methylpyrimidin-2-yl)butane-2-sulfonamide | C9H15N3O2S |
| 2050057-56-0 | Upadacitinib hemihydrate;(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;hydrate | C34H40F6N12O3 |
| 2051921-49-2 | 2,6-Dichloro-3-fluoropyridin-4-amine | C5H3Cl2FN2 |
| 2054317-97-2 | (R)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-amine;(1R)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethanamine | C10H11FN4 |
| 2055038-63-4 | Efinaconazole N-Oxide Impurity 1;(2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidene-1-oxidopiperidin-1-ium-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol | C18H22F2N4O2 |
| 2055043-54-2 | tert-Butyl (4R)-4-(aminomethyl)-3,3-difluoropiperidine-1-carboxylate | C11H20F2N2O2 |
| 2055043-62-2 | tert-Butyl (4S)-4-(aminomethyl)-3,3-difluoropiperidine-1-carboxylate | C11H20F2N2O2 |
| 2055761-19-6 | (3S,4S)-3-Methyl-2-oxa-8-azaspiro[4.5]decan-4-amine dihydrochloride | C9H20Cl2N2O |
| 2055841-26-2 | 4-Amino-3-fluoro-2-methylbenzonitrile | C8H7FN2 |
| 2055841-42-2 | 3-Bromo-2,4,5-trifluorobenzenamine | C6H3BrF3N |
| 2055858-27-8 | Bis(3,5-difluorophenyl)sulfoxide;1-(3,5-difluorophenyl)sulfinyl-3,5-difluorobenzene | C12H6F4OS |
| 2056261-41-5 | BRD0705;(4S)-4-ethyl-7,7-dimethyl-4-phenyl-1,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | C20H23N3O |
| 2056261-42-6 | BRD5648;(4R)-4-ethyl-7,7-dimethyl-4-phenyl-1,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | C20H23N3O |
| 2056262-07-6 | BRD3731;(4S)-3-(2,2-dimethylpropyl)-4,7,7-trimethyl-4-phenyl-2,6,8,9-tetrahydropyrazolo[3,4-b]quinolin-5-one | C24H31N3O |